Association of BDNF gene polymorphisms with schizophrenia and clinical symptoms in a Chinese population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 6, 2013, Pages 538-545

  Li, Wenjun ^a   Zhou, Na ^a   Yu, Qiong ^a   Li, Xiaokun ^a   Yu, Yaqin ^a   Sun, Shilong ^a   Kou, Changgui ^a   Chen, Da Chun ^b   Xiu, Mei Hong ^b   Kosten, Thomas R ^b,c   Zhang, Xiang Yang ^b,c  

^a JILIN UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Association; Brain derived neurotrophic factor; Haplotype; Negative symptom; Polymorphism; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; PERPHENAZINE; RISPERIDONE; SULPIRIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MONOTHERAPY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUANTITATIVE TRAIT; SCHIZOPHRENIA;

ASSOCIATION; BRAIN-DERIVED NEUROTROPHIC FACTOR; HAPLOTYPE; NEGATIVE SYMPTOM; POLYMORPHISM; SCHIZOPHRENIA;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; SCHIZOPHRENIA;

EID: 84881486039     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32183     Document Type: Article

References (52)

1. Alemany S, Arias B, Aguilera M, Villa H, Moya J, Ibáñez MI., et al. 2011. Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. Br J Psychiatry 199(1):38-42.
2. Binder DK, Scharfman HE. 2004. Brain-derived neurotrophic factor. Growth Factors 22:123-131.
3. Buckley PF, Pillai A, Howell KR. 2011. Brain-derived neurotrophic factor: Findings in schizophrenia. Curr Opin Psychiatry 24:122-127.
4. Chang HA, Lu RB, Shy MJ, Chang CC, Lee MS, Huang SY. 2009. Brain-derived neurotrophic factor Val66Met polymorphism: Association with psychopathological symptoms of schizophrenia? J Neuropsychiatry Clin Neurosci 21:30-37.
5. Chen QY, Chen Q, Feng GY, Wan CL, Lindpaintner K, Wang LJ, et al. 2006. Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population. Neurosci Lett 397:285-290.
6. Chen CY, Lu RB, Yeh YW, Shih MC, Huang SY. 2011. Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes Brain Behav 10(3):316-324.
7. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2):115-121.
8. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Human Heredity 66(2):87-98.
9. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A., et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNFand human memory and hippocampal function. Cell 112(2):257-269.
10. First MB, Spitzer RL, Gibbon M, Williams JBW. 2002. Structured clinical interview for DSM-IV-TR. Axis I disorders, research version, patient edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute.
11. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. 2002. The structure of haplotype blocks in the human genome. Science 296(5576):2225-2229.
12. Gauderman WJ. 2002. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155(5):478-484.
13. Gourion D, Gourevitch R, Leprovost JB, Olié H, lôo JP, Krebs MO. 2004. Neurodevelopmental hypothesis in schizophrenia. Encephale 30(2):109-118.
14. Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ. 2011. Brain-derived neurotrophic factor levels in schizophrenia: A systematic review with meta-analysis. Mol Psychiatry 16(9):960-972.
15. Hong CJ, Yu YW, Lin CH, Tsai SJ. 2003. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 349:206-208.
16. Jönsson EG, Edman-Ahlbom B, Sillén A, Gunnar A, Kulle B, Frigessi A., et al. 2006. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 30:924-933.
17. Kawashima K, Ikeda M, Kishi T, Kitajima T, Yamanouchi Y, Kinoshita Y., et al. 2009. BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophr Res 112:72-79.
18. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276.
19. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J. 2007. Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20:687-702.
20. Lee WC. 2003. Detecting population stratification using a panel of single nucleotide polymorphisms. Int J Epidemiol 32:1120.
21. Lencz T, Lipsky RH, DeRosse P, Burdick KE, Kane JM, Malhotra AK. 2009. Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry 194(4):313-3318.
22. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33(2):177-182.
23. Lu L, Mamiya T, Koseki T, Mouri A, Nabeshima T. 2011. Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment. Biol Pharm Bull 34(9):1358-1363.
24. McGrath J, Saha S, Chant D, Welham J. 2008. Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67-76.
25. Muglia P, Vicente AM, Verga M, King N, Macciardi F, Kennedy JL. 2003. Association between the BDNF gene and schizophrenia. Mol Psychiatry 8(2):146-147.
26. Naoe Y, Shinkai T, Hori H, Fukunaka Y, Utsunomiya K, Sakata S., et al. 2007. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis. Neurosci Lett 415:108-112.
27. Nawa H, Takahashi M, Patterson PH. 2000. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol Psychiatry 5(6):594-603.
28. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, et al. 2005. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10:208-212.
29. Nicodemus KK, Marenco S, Batten AJ, Vakkalanka R, Egan MF, Straub RE, Weinberger DR. 2008. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry 13:873-877.
30. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K., et al. 2006. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett 401:1-5.
31. Nyholt DR. 2004. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74(4):765-769.
32. Pivac N, Nikolac M, Nedic G, Mustapic M, Borovecki F, Hajnsek S, et al. 2011. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 35(2):356-362.
33. Qian L, Zhao J, Shi Y, Zhao X, Feng G, Xu F, et al. 2007. Brain-derived neurotrophic factor and risk of schizophrenia: An association study and meta-analysis. Biochem Biophys Res Commun 353:738-743.
34. Reis HJ, Nicolato R, Barbosa IG, Teixeira do, Prado PH, Romano-Silva MA, Teixeira AL. 2008. Increased serum levels of brain derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett 439:157-159.
35. Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D., et al. 2008. Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32:1308-1311.
36. Rosa A, Cuesta MJ, Fatjo-Vilas M, Peralta V, Zarzuela A, Fananas L. 2006. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am J Med Genet Part B 141B:135-138.
37. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, et al. 2005. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58(4):307-314.
38. Suchanek R, Owczarek A, Kowalski J. 2012. Association study between BDNF C-281A polymorphism and paranoid schizophrenia in polish population. J Mol Neurosci 46(1):217-222.
39. Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY. 2005. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Neurosci Lett 382(1-2):27-32.
40. Tao R, Wei J, Guo Y, Yu Y, Xu Q, Shi J., et al. 2006. The PLA2G4A gene and negative symptoms in a Chinese population. Schizophr Res 86:326-328.
41. Van Os J, Kapur S. 2009. Schizophrenia. Lancet 374(9690):635-645.
42. van Winkel R, Stefanis NC, Myin-Germeys I. 2008. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 34:1095-1105.
43. Wang Y, Wang JD, Wu HR, Zhang BS, Fang H, Ma QM, et al. 2010. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is not associated with risk for schizophrenia and tardive dyskinesia in Han Chinese population. Schizophr Res 120:240-242.
44. Watanabe Y, Muratake T, Kaneko N, Nunokawa A, Someya T. 2006. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr Res 84(1):29-35.
45. Watanabe Y, Nunokawa A, Kaneko N, Someya T. 2007. Meta-analysis of case-control association studies between the C270T polymorphism of the brain-derived neurotrophic factor gene and schizophrenia. Schizophr Res 95(1-3):250-252.
46. Waterhouse EG, Xu B. 2009. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 42:81-89.
47. Woods SW. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64(6):663-667.
48. Xu MQ, St Clair D, Ott J, Feng GY, He L. 2007. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res 91:6-13.
49. Yeh YW, Lu RB, Tao PL, Shih MC, Lin WW, Huang SY. 2010. Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. Genes Brain Behav 9(6):638-647.
50. Zai CC, Manchia M, De Luca V, Tiwari AK, Squassina A, Zai GC, Strauss J, et al. 2010. Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs. Prog Neuropsychopharmacol Biol Psychiatry 34:1412-1418.
51. Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Xu Q, et al. 2007. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. J Psychiatr Res 41(12):997-1004.
52. Zintzaras E. 2007. Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: A meta-analysis. Psychiatr Genet 17:69-75.